logo
Dublin Stock Exchange considering extended trading hours

Dublin Stock Exchange considering extended trading hours

Irish Post20 hours ago
EURONEXT Dublin has said it does not see an immediate need to extend its trading hours, but is paying attention to growing international momentum toward longer or near-24-hour trading windows.
The exchange, which operates from 8am to 4:30pm, is maintaining its current schedule while continuing to consult with market participants on the issue.
'Euronext is continuously engaging with its clients on the extension of trading hours, and no clear consensus is yet emerging,' the company said. 'Some participants are more in favour of shortening the number of trading hours.'
The London Stock Exchange, which shares the same operating hours as Dublin, is considering 24-hour trading, according to a report in the Financial Times.
In the United States, major exchanges are actively pushing for longer hours.
The New York Stock Exchange has proposed extending trading on its NYSE Arca platform to 22 hours a day.
Nasdaq and the Cboe options exchange are also planning to expand their trading windows, and the Securities and Exchange Commission has given preliminary approval for the launch of a new venue, the 24X National Exchange, that would trade almost continuously.
Euronext Dublin, previously the Irish Stock Exchange, was acquired by the pan-European operator Euronext in 2018.
It now forms part of a group that also includes exchanges in Amsterdam, Brussels, Lisbon, Milan, Oslo, and Paris.
The Dublin market is used by over 4,000 issuers from more than 85 countries and lists over 35,000 securities.
It plays a significant role in the Irish economy, with a 2014 study by Indecon estimating that the domestic securities industry supported 2,100 jobs and contributed €207 million annually in direct economic impact, including €230 million in direct tax revenue.
While Euronext has not made changes to its main equity trading window, it does already provide extended hours in some market segments.
For example, warrants and certificates can be traded until 10pm Central European Time (CET), and after-hours equity trading is available until 8:30pm CET. CET is two hours ahead of Irish time.
The company added, 'Given that there is no consensus among industry participants on buy-side, sell-side and industry associations, Euronext doesn't see an immediate need to take action to review its overall trading hours.'
Euronext has also been advocating for changes to post-trade infrastructure as part of a wider industry move toward T+1 settlement, where trades settle one day after execution rather than the standard two.
This would bring European markets closer to the direction being taken by the US.
The push for longer trading hours globally is partly driven by increased retail investor activity via mobile platforms like Robinhood, Charles Schwab and Webull, as well as by the 24/7 nature of cryptocurrency markets.
According to Nasdaq's head of marketplace technology, Magnus Haglind, demand for extended trading is currently concentrated in US markets, but 'we see across our global client base that it's an emerging trend that is likely to spread across other markets.'
However, some market participants have raised concerns about the implications of near-continuous trading.
One risk is that large institutional investors could act on information during extended hours, leaving smaller shareholders exposed to sudden price movements while markets are less liquid and many investors are offline.
Euronext Dublin remains open to adjusting its hours in the future but has made clear that any decision would be client-driven.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

European negotiators head for Washington after Trump agrees Japan deal
European negotiators head for Washington after Trump agrees Japan deal

Irish Examiner

timean hour ago

  • Irish Examiner

European negotiators head for Washington after Trump agrees Japan deal

European shares climbed early on Wednesday, led by automobile stocks, after US president Donald Trump revived hopes for a trade deal with the European Union following an agreement with Japan. European automobile stocks led a broad-based rally, rising 3.6%, tracking strength in Asian rivals. Carmakers such as Mercedes-Benz, Volkswagen, and Porsche gained between 7.4% and 5.1%. Mr Trump struck a trade deal with Japan, lowering tariffs on auto imports and sparing Tokyo from punishing new levies on other goods in exchange for a $550bn (€468bn) package of US-bound investment and loans. The Japan deal included reduced 15% tariffs for auto exports to the US, down from 25% earlier. Meanwhile, the prospects of an EU-US trade agreement improved after Mr Trump said that EU representatives would come for trade negotiations on Wednesday. "The message is that things are negotiable," said RBC Brewin Dolphin's head of market analysis, Janet Lui, mentioning how Japan faced similar difficulties in reaching a tariff consensus with the U.S. "The read across is there is potential to reach a trade deal that's lifting European markets across the board." Among individual stocks, Temenos gained 18.1%, the biggest gainer in the STOXX 600, after the banking software company raised its full-year earnings forecast. UniCredit rose 3.4% after the Italian lender posted higher-than-expected quarterly profit and raised its fiscal-year outlook. Lonza rose 6.3% after the Swiss company topped core profit forecast. Conversely, Nokia slumped 7.7%, pressuring media stocks, after the Finnish group lowered its guidance for 2025 comparable operating profit on Tuesday. ASM International fell the most in the benchmark index, down 9.3%, after the computer chip equipment maker reported second-quarter bookings below market expectations. SAP fell 2.5% after the German software maker reported a positive second-quarter profit on cost cuts and increased demand. Meanwhile, the latest earnings forecasts showed on Tuesday that the outlook for European corporate health has slightly improved. On the day, Alphabet and Tesla will kick off the results season for the "Magnificent Seven" stocks. Investors will also focus on euro zone consumer confidence flash for July later in the day. Meanwhile Mr Trump said on Tuesday he would use import restrictions to force foreign suppliers to cut drug prices and that pharmaceutical companies would have a lot of problems if they did not agree to bring prices down. Speaking at the White House at an event with Republican lawmakers, Trump pledged to reduce what consumers must pay for prescription drugs.

Irish biotech Ovagen believes study can 'transform' global vaccine manufacture
Irish biotech Ovagen believes study can 'transform' global vaccine manufacture

Irish Examiner

time2 hours ago

  • Irish Examiner

Irish biotech Ovagen believes study can 'transform' global vaccine manufacture

Groundbreaking results achieved by Irish biotech Ovagen Group could "transform the economics of global vaccine manufacturing", the company said on Wednesday. The company carried out its breakthrough study into yellow fever virus yield. Conducted at the UK's Pirbright Institute, the comparative study showed that Ovagen's Germ Free embryonated chicken eggs delivered up to 7,600 doses of yellow fever virus per egg compared to just 422 doses per egg using current industry standards. Speaking about the results of the study, Dr. Catherine Caulfield, CEO of Ovagen said: "What we have developed isn't incremental, it's a complete rethink of the vaccine manufacturing process," said Ovagen chief executive Dr Catherine Caulfield. "Our germ free egg platform eliminates bacterial contamination and reduces the need for antibiotics in vaccine production, while delivering significantly higher viral yield. "This is high-impact science with high-value commercial outcomes.' The comparative study showed that Ovagen's Germ Free embryonated chicken eggs delivered up to 7,600 doses of yellow fever virus 17D per egg compared to just 422 doses per Specified Pathogen-Free (SPF) Egg using current industry standards. With a current global shortfall of 60m yellow fever vaccines per year, Ovagen's technology can help scale up production of yellow fever vaccine production by reducing reliance on key raw material inputs such as SPF eggs, antibiotics, and downstream processing resources. More than 140,000 eggs would be required to satisfy the current global shortfall using current industry standards compared with just 7,894 eggs using Ovagen's technology. The improved yield also dramatically reduces the volume of antibiotics typically required in conventional egg-based manufacturing, helping to mitigate risks associated with antimicrobial resistance and lowering overall production costs. Based in Co Mayo, Ovegen has been supported over €21m in funding from Enterprise Ireland, private investors, promoters funds, venture capital, and the European Innovation Council. Ovagen operates from a purpose-built state-of-the-art facility and has successfully completed pilot trials with major vaccine manufacturers. 'Enterprise Ireland is proud to support Ovagen as they continue to scale their innovation and ambition. Their germ-free egg technology shows real potential to drive greater efficiency in vaccine manufacturing, and it's encouraging to see this level of innovation emerging from the West of Ireland. Ovagen's progress highlights the strength of Ireland's biotech sector and the impact that Irish companies can have on global health challenges," said Enterprise Ireland head of industrial and life sciences Tom Cusack.

Cork-based accounting firm to create 400 jobs as revenues sore
Cork-based accounting firm to create 400 jobs as revenues sore

Irish Independent

time3 hours ago

  • Irish Independent

Cork-based accounting firm to create 400 jobs as revenues sore

Ifac has four offices across the county in Bandon, Blarney, Mallow and Skibbereen, and is celebrating 50 years in operation this year. The firm has 30 offices scattered across Ireland, supporting over 30,000 clients. Through their services, they support 18,000 producers, 3,000 clients in the agri-food sector, and 7,000 SMEs with a full range of professional services, including accounting, tax, audit, corporate finance, consultancy, corporate recovery, payroll, financial planning, company secretarial, and business valuations. With revenues expected to hit €50 million, Ifac has transformed from its humble beginnings to become a top ten accountancy and advisory firm. The firm began as a specialist advisor to Irish farmers and has seen remarkable growth, from undergoing a successful rebrand in 2018 to expanding its services in farming, food, agri-business, the SME space, tax, and audit, thereby meeting and exceeding client needs. Founding chair Donal Cashman said the firm is investing in the communities they operate in. 'While the firm will continue to respect its heritage, it will continue to grow with Irish farmers and producers, alongside expanding into new markets. 'Its focus today is very much on continuous improvement, most recently marked by the launch of a new specialist team for mid to large SMEs. 'And as Ifac enters its next chapter, its mission remains unchanged: to help clients succeed on the farm, in business, and beyond,' Mr Cashman said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store